If you took an SSRI during the first trimester of pregnancy and your child was diagnosed with Persistent Pulmonary Hypertension (PPHN) or other breathing-related difficulties at birth, please contact the birth injury attorneys at Simmons Hanly Conroy right away for advice on SSRI lawsuits. You may be entitled to compensation.
FILING A BIRTH INJURY LAWSUIT WITH THE SIMMONS LAW FIRM
If your child was diagnosed with Persistent Pulmonary Hypertension (PPHN) at birth, and you have taken Paxil or any other selective serotonin reuptake inhibitors (SSRI) antidepressant during the first trimester of pregnancy, please contact our birth injury lawyers right away.
Even if PPHN was not specifically diagnosed, if you took an SSRI and your child had breathing-related difficulties at birth and is now experiencing developmental delays, we’d like to talk to you. The firm birth injury attorneys may be able to shed light on the benefits of filing a birth injury lawsuit, based on your circumstances.
ABOUT SSRIS AND PREGNANCY
Millions of women have turned to prescription antidepressants and lacking adequate warnings from pharmaceutical manufacturers, continue to take the drugs while they are pregnant. Some of these drugs include:
- Celexa Lawsuits
- Cipralex Lawsuits
- Effexor Lawsuits
- Luvox Lawsuits
- Paxil Lawsuits
- Prozac Lawsuits
- Remeron Lawsuits
- Zoloft Lawsuits
One particular class of antidepressants – called selective serotonin reuptake inhibitors (SSRI) – has been linked to serious birth defects when taken during pregnancy. In particular, SSRIs have been linked to Persistent Pulmonary Hypertension in Newborns (PPHN).
If you took an SSRI during the first trimester of pregnancy, and your newborn had respiratory complications during his or her first minutes of life, our birth injury attorneys would like to speak with you. If your child experienced respiratory problems at birth and is now experiencing developmental delays, our attorneys would also like to speak with you. There is a good chance these delays were caused by PPHN, which in turn may be linked to the medications.
Led by named shareholders Paul Hanly and Jayne Conroy, Simmons Hanly Conroy attorneys are investigating the link between SSRIs and PPHN and whether drug manufacturers hid the dangers of the popular medications.
On July 19, 2006, the FDA issued a public health warning and urged the manufacturers of certain SSRI-antidepressants to change their prescribing information to describe the potential risk of PPHN.
The FDA warns that infants exposed to SSRIs during the first trimester who have developed respiratory complications requiring prolonged hospitalization, respiratory support, and tube feeding and may be at risk for Persistent Pulmonary Hypertension of the Newborn (PPHN).
If you took an SSRI during the first trimester of pregnancy, and your newborn had respiratory complications during his or her first minutes of life, we would like to speak with you. Please contact us today.
I am very pleased and had a wonderful experience with the firm. Would definitely use their services again.